Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Helping Stroke Patients With ThermoSuit Cooling
Status: Enrolling
Updated: 12/31/1969
Rapides Regional Medical Center
mi
from
Alexandria, LA
Click here to add this to my saved trials
Hodgkin's Lymphoma Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)
Status: Enrolling, Phase II
Updated: 3/3/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Hodgkin's Lymphoma Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)
Status: Enrolling, Phase II
Updated: 3/3/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Chance T. Kaplan, M.D.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Breast Implant Clinical Trial
Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Status: Enrolling, Phase
Updated: 12/31/1969
Danielle LeBlanc, MD
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
Greater Austin Allergy, Asthma, & Immunology
mi
from
Round Rock, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
MSPT Device Usability Study
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
MSPT Device Usability Study
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Treatment Centers of America-Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Presbyterian Rust Medical Center/Jorgensen Cancer Center
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Abington Memorial Hospital-Asplundh Cancer Pavilion
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Calgary,
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westwood, KS
Click here to add this to my saved trials
Solid Tumor Clinical Trial
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Helen Diller Fam Comp Can Ctr
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Mantle Cell Lymphoma (MCL) Clinical Trial
A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Mantle Cell Lymphoma (MCL) Clinical Trial
A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
Status: Enrolling
Updated: 12/31/1969
Northwell Health
mi
from
Manhasset, NY
Click here to add this to my saved trials
Aortic Valve Stenosis Clinical Trial
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
Status: Enrolling
Updated: 12/31/1969
University Hospital Salt Lake City Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Carolina of Huntersville
mi
from
Huntersville, NC
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Biological Signatures, Probiotic Among Those With mTBI and PTSD
Status: Enrolling, Phase I
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tarzana, CA
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Cancer Specialists; Department of Oncology
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling, Phase II
Updated: 12/31/1969
Sarah Cannon Cancer Center
mi
from
Germantown, TN
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling, Phase II
Updated: 12/31/1969
Capitol Comprehensive CA Care
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling, Phase II
Updated: 12/31/1969
Comp Cancer Centers of Nevada
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neoplasm Metastasis Clinical Trial
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Cancer Specialists - Tampa (Dr. MLK Blvd)
mi
from
Tampa, FL
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
NANI Research
mi
from
Hinsdale, IL
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Genesis Clinical Research Corp
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering West Harrison
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Franklin, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Middlebury, CT
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
McLaren Cancer Institute-Bay City
mi
from
Bay City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
New York-Presbyterian/Brooklyn Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Crozer-Keystone Regional Cancer Center at Broomall
mi
from
Broomall, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
mi
from
Lake Success, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
McLaren Cancer Institute-Northern Michigan
mi
from
Petoskey, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
21st Century Oncology MHP - Troy
mi
from
Troy, MI
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Brain and Spine Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health at Lakewood Hospital
mi
from
Lakewood, OH
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
The Birches at Newton / Family Medical Associates
mi
from
Levittown, PA
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Flora Baker Center for Alzheimer's Disease and Related Disorders
mi
from
Marmora, NJ
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Project 4 Research
mi
from
Miami, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Dade Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory Brain Health Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Herbert Harris, MD, PHD, PA
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
RH Johnson VA Medical Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Innova Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
The Neurology Research Group, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Kendall Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Sensible Healthcare
mi
from
Ocoee, FL
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling, Phase III
Updated: 12/31/1969
Neurology Research Institute Palm Beach
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Alvocidib Biomarker-driven Phase 2 AML Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Honor Health Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research of Miami
mi
from
Doral, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dolphin Medical Research
mi
from
Doral, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Professionals, LLC - Olde Cabin Rd
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Charm City Research Group
mi
from
Towson, MD
Click here to add this to my saved trials
Hepatocellular Carcinoma (HCC) Clinical Trial
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Status: Enrolling, Phase III
Updated: 12/31/1969
Site No. 8409
mi
from
Adelaide,
Click here to add this to my saved trials